Review
Copyright ©The Author(s) 2015.
World J Diabetes. Jul 10, 2015; 6(7): 896-911
Published online Jul 10, 2015. doi: 10.4239/wjd.v6.i7.896
Table 1 Thresholds defining the metabolic syndrome issued by individual organisations
WHO 1998 (Alberti 1998)EGIR (Balkau 1999)NCEP/ATP III 2001 (NCEP 2002)AACE (2003) (Einhorn 2003)IDF consensus 2005 (Zimmet 2005)IDF consensus (10 to < 16 yr) (Zimmet 2007)
DefinitionIGT, IFG, T2DM or lowered insulin sensitivityPlasma insulin > 75th percentile3 of the followingIGT or IFG plus any of the following based on clinical judgementSee below
Plus 2 of the followingPlus 2 of the following
Europoid waistW:H > 0.90 M≥ 94 M≥ 102 MBMI ≥ 25 kg/m2≥ 94 M> 90th percentile
circumference (cm)W:H > 0.85 F or BMI > 30 kg/m2≥ 80 F≥ 88 F≥ 80 F or BMI > 30 kg/m2Plus 2 of the following
Plus 2 of the following
Triglyceride [mg/dL (mmol/L)]> 150 (1.7)> 150 (1.7)≥ 150 (1.7)> 150 (1.7)> 150 (1.7)≥ 150 (1.7)
HDL [mg/dL (mmol/L)]< 35 (0.91) M< 39 (0.91)< 40 (1.03) M< 40 (1.03) M< 40 (1.03) M< 40 (1.03)
< 39 (1.01) F< 50 (1.29) F< 50 (1.29) F< 50 (1.29) F
BP (mmHg)≥ 140/90≥ 140/90 or on treatment≥ 130/85≥ 130/85SBP ≥ 130 or DBP ≥ 85 or on treatmentSBP ≥ 130 and/or DBP ≥ 85
Glucose [mg/dL (mmol/L)]IGT, IFG or T2DMIGT or IFG (but not diabetes)≥ 100 (5.6) (Grundy) or diabetesIGT or IFG (but not diabetes)≥ 100 (5.6)≥ 100 (5.6) or known T2DM
OthersMicroalbuminuria ACR > 30 mg/gOther features of IR1